NEURAXIS, INC. Derivative, Gain (Loss) on Derivative, Net
NEURAXIS, INC. (NRXS) reported Derivative, Gain (Loss) on Derivative, Net of $198.55 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2025-03-20.
Financial Statements › Income Statement › Other Income
us-gaap:DerivativeGainLossOnDerivativeNet · last filed 2025-03-20
- NEURAXIS, INC. derivative, gain (loss) on derivative, net for the quarter ending 2023-12-31 was $0.00, a 100.00% decline year-over-year.
- NEURAXIS, INC. derivative, gain (loss) on derivative, net for the quarter ending 2023-09-30 was $6.39K.
- NEURAXIS, INC. derivative, gain (loss) on derivative, net for the quarter ending 2023-06-30 was $860.00.
- NEURAXIS, INC. derivative, gain (loss) on derivative, net for the quarter ending 2023-03-31 was $191.30K.
- NEURAXIS, INC. derivative, gain (loss) on derivative, net for fiscal 2023 was $198.55K, a 72.19% decline from fiscal 2022.
- NEURAXIS, INC. derivative, gain (loss) on derivative, net for fiscal 2022 was $713.99K.
| Period end | Derivative, Gain (Loss) on Derivative, Net 3 month | Derivative, Gain (Loss) on Derivative, Net 6 month | Derivative, Gain (Loss) on Derivative, Net 9 month | Derivative, Gain (Loss) on Derivative, Net 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $6.39K derived: sum of 2 quarters · filed 2025-03-20 | $7.25K derived: sum of 3 quarters · filed 2025-03-20 | $198.55K 10-K · filed 2025-03-20 |
| 2023-09-30 | $6.39K 10-Q · filed 2024-11-12 | $7.25K derived: sum of 2 quarters · filed 2024-11-12 | $198.55K 10-Q · filed 2024-11-12 | $980.57K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $860.00 10-Q · filed 2024-08-09 | $192.16K 10-Q · filed 2024-08-09 | $974.18K derived: sum of 3 quarters · filed 2024-08-09 | $906.15K derived: sum of 4 quarters · filed 2024-08-09 |
| 2023-03-31 | $191.30K 10-Q · filed 2024-05-20 | $973.32K derived: sum of 2 quarters · filed 2024-05-20 | $905.29K derived: sum of 3 quarters · filed 2024-05-20 | |
| 2022-12-31 | $782.02K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | $713.99K derived: sum of 2 quarters · filed 2024-04-16 | $713.99K 10-K · filed 2024-04-16 | |
| 2022-09-30 | -$68.03K 10-Q · filed 2023-11-20 | -$68.03K 10-Q · filed 2023-11-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| EDAP TMS SA (FOCL) | $0.171B | ||
| IRIDEX CORP (IRIX) | United States | $0.011B |